Trends of kidney cancer burden from 1990 to 2019 in European Union 15 + countries and World Health Organization regions

• Published in: Scientific reports Vol. 12; no. 1; p. 22368
• Main Authors: Jani, Chinmay, Abdallah, Nour, Mouchati, Christian, Jani, Ruchi, Sharma, Rajesh, Bhatt, Padmanabh, Hanbury, Georgina, Salciccioli, Justin, Singh, Harpreet, Shalhoub, Joseph, McKay, Rana R., Marshall, Dominic C.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 26.12.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 631/67; 692/308; 692/4028; Age; Austria; European Union; Female; Females; Global Health; Humanities and Social Sciences; Humans; Incidence; Kidney cancer; Kidney Neoplasms - epidemiology; Kidneys; Male; Mortality; multidisciplinary; Science; Science (multidisciplinary); Trends; World Health Organization; Austria
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-25485-8

In recent decades, variability in the incidence and mortality of kidney cancer (KC) has been reported. This study aimed to compare trends in incidence, mortality, and disability-adjusted life years (DALY) of KC between the European Union (EU) 15 + countries and 6 World Health Organization (WHO) regions. The data of KC Age-standardized incidence rates (ASIRs), age-standardized mortality rates (ASMRs), and age-standardized DALYs were extracted from the Global Burden of Disease database. Joinpoint regression was employed to examine trends. From 1990 to 2019, the ASIR increased in most countries except for Luxembourg (males), the USA (females) and Austria and Sweden (both sexes). ASIR increased across all 6 WHO regions for both sexes except for females in Americas. The ASMR increased in 10/19 countries for males and 9/19 for females as well across most WHO regions. The mortality-to-incidence ratio (MIR) decreased in all countries and WHO regions. Trends in DALYs were variable across countries and WHO regions. While the incidence and mortality from KC rose in most EU15 + countries and WHO regions from 1990 to 2019, the universal drop in MIR suggests an overall improvement in KC outcomes. This is likely multifactorial, including earlier detection of KC and improved treatments.